What Venlafaxine does
Venlafaxine is the prototype SNRI. At low doses it acts primarily as a serotonin reuptake inhibitor; at higher doses (above roughly 150 mg) it adds meaningful norepinephrine reuptake inhibition, useful for patients with comorbid pain or fatigue.
What the evidence says for Black patients
Venlafaxine is metabolized to its active metabolite desvenlafaxine (Pristiq) by CYP2D6. CYP2D6 poor metabolizers, more common in some Black populations for certain alleles, may have higher venlafaxine levels and lower desvenlafaxine levels, potentially affecting both efficacy and side effects. No specific race-based dosing recommendation exists; genotype-guided dosing remains reasonable when response or tolerability is suboptimal.
For depression response in Black participants of STAR*D step 2 (venlafaxine switch arm), remission rates were similar to white participants after adjusting for comorbid conditions.
A practical caution: venlafaxine raises blood pressure at higher doses (>225 mg). Because Black adults have higher baseline BP and elevated hypertension-related risk, a BP check before dose escalation is appropriate.
How your genes can change this drug
Some people process venlafaxine differently because of an inherited gene variant, and the difference is large enough that prescribing guidelines address it. The recommendations below are published by CPIC, the Clinical Pharmacogenetics Implementation Consortium, and are quoted as written. They are guidance for prescribers, not instructions to change your own dose.
No action recommended based on genotype for venlafaxine because of minimal evidence regarding the impact on efficacy or side effects. Initiate therapy with recommended starting dose. Consider a clinically appropriate alternative antidepressant not predominantly metabolized by CYP2D6. No recommendation
Genetic testing for these variants is available but is not routine. If you have had a reaction to this drug, or it has not worked for you, this is worth raising with your prescriber. Do not stop or change a prescription on your own.
Common alternatives
Duloxetine (Cymbalta), a longer-half-life SNRI. Desvenlafaxine (Pristiq) avoids CYP2D6 conversion. SSRIs (sertraline, escitalopram) for first-line if comorbid pain is not a concern.
Side effects
- Nausea (worst of common SNRI/SSRI)
- Sexual dysfunction
- Dose-dependent blood pressure rise
- Severe discontinuation syndrome (second only to paroxetine), must taper
- Insomnia, activation
- Sweating
- Boxed warning, suicidality in young adults
Factors that affect adherence
XR formulation smooths the plasma profile and is usually better tolerated. Never stop abruptly, discontinuation is notoriously difficult. Generic venlafaxine XR is inexpensive.
Questions to ask your doctor
Bring this list to your next appointment.
- Will we check my blood pressure as we go up in dose?
- If I've had sexual side effects, is bupropion or mirtazapine a better fit?
- What's the taper plan if we need to stop?
References
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression (STAR*D). NEJM. 2006;354:1231 to 1242.
- Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology. 1995;12:185 to 219.
- U.S. Food and Drug Administration. Effexor XR (venlafaxine hydrochloride) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020699s109lbl.pdf
Medical disclaimer
This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients, it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.
Read our editorial standards for how we source, review, and update these pages.